injection site reaction glp 1 Dermal Hypersensitivity to Semaglutide: Two Case Reports - JDDonline Hypersensitivity to glucagon‐like peptide‐1 receptor

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of alzheimers disease

Providing assistance to those who truly need it.

The increasing prevalence of MASLD mirrors the global obesity and type 2 diabetes mellitus epidemic, reflecting common pathophysiological pathways rooted in metabolic dysfunction

Nevertheless, there is no doubt that GLP-1 interacts with vagal afferent neurons and the arcuate nucleus of the hypothalamus, critical components of the gut-brain axis that connect peripheral metabolic signals to the central nervous system [10]

Other research on retinopathy and other eye problems is mixed